Search research articles
Contact Us
Filters
Showing results (191-200 of 207) with videos related to
Page
of 21
Sort By:
European Urology Oncology
|
February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging
Ting Martin Ma, Andrei Gafita, David Shabsovich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2023
Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database
Louise Emmett, Nathan Papa, William Counter, et al.
European Urology
|
July 23, 2023
Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial
Loïc Djaïleb, Wesley R Armstrong, Daniel Thompson, et al.
JCO Precision Oncology
|
July 16, 2024
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study
John Nikitas, Kritika Subramanian, Nimrod Barashi Gozal, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 14, 2021
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond
Ting Martin Ma, Soumyajit Roy, Xue Wu, et al.
The Journal of Urology
|
May 17, 2024
Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer
Louise Emmett, Nathan Papa, Thomas A Hope, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 12, 2025
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study
Amar U Kishan, Luca F Valle, Holly Wilhalme, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2023
Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT)
Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber, et al.
European Urology
|
September 18, 2024
Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer
Adam B Weiner, Raag Agrawal, Nicholas K Wang, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 207) with videos related to
Sort By:
Page
of 21
European Urology Oncology
|
February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging
Ting Martin Ma, Andrei Gafita, David Shabsovich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2023
Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database
Louise Emmett, Nathan Papa, William Counter, et al.
European Urology
|
July 23, 2023
Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial
Loïc Djaïleb, Wesley R Armstrong, Daniel Thompson, et al.
JCO Precision Oncology
|
July 16, 2024
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study
John Nikitas, Kritika Subramanian, Nimrod Barashi Gozal, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 14, 2021
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond
Ting Martin Ma, Soumyajit Roy, Xue Wu, et al.
The Journal of Urology
|
May 17, 2024
Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer
Louise Emmett, Nathan Papa, Thomas A Hope, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 12, 2025
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study
Amar U Kishan, Luca F Valle, Holly Wilhalme, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2023
Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT)
Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber, et al.
European Urology
|
September 18, 2024
Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer
Adam B Weiner, Raag Agrawal, Nicholas K Wang, et al.
Page
of 21